ReviewDiabetology & metabolic syndrome2022

Network meta-analysis on the efficacy and safety of finerenone versus SGLT2 inhibitors on reducing new-onset of atrial fibrillation in patients with type 2 diabetes mellitus and chronic kidney disease.

Yaofu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.